Impact of clinical pharmacist intervention on taxane-related lymphedema among breast cancer patients

Basit Öğe Kaydı
dc.contributor.authorKoseoglu, A.
dc.contributor.authorAl-Taie, A.
dc.date.accessioned2024-05-19T14:51:31Z
dc.date.available2024-05-19T14:51:31Z
dc.date.issued2022
dc.departmentİstinye Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage1520en_US
dc.identifier.issn2210-7703
dc.identifier.issn2210-7711
dc.identifier.issue6en_US
dc.identifier.startpage1519en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12713/5960
dc.identifier.volume44en_US
dc.identifier.wosWOS:000926482000151en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofInternational Journal of Clinical Pharmacyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subject[No Keywords]en_US
dc.titleImpact of clinical pharmacist intervention on taxane-related lymphedema among breast cancer patientsen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu